Siteman Investment Program awards $2 million in cancer research grants

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is pleased to announce funding for eight new projects, including research projects focused on prostate cancer, lymphoma, and breast cancer, as well as a team science project with a focus on myeloproliferative neoplasms, a blood malignancy that can develop into acute myeloid leukemia. Also included are two new clinical trials, one aiming to devise a more personalized treatment strategy for breast cancer in Black patients and another examining the efficacy of a novel drug treatment for patients with cutaneous T-cell lymphoma (CTCL).